Role of endothelin-1 in congestive gastropathy in portal hypertensive rats

Shinichiro Migoh, Makoto Hashizume, Kouji Tsugawa, Kazuo Tanoue, Keizo Sugimachi

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)


Background: The aim of this study was to determine the role of endothelin (ET)-1 in portal hypertensive gastropathy (PHG) under portal hypertension, in order to investigate whether the ET(A/B) receptor inhibitor improves the permeability of gastric mucosal microvessels in PHG. Methods and Results: Portal hypertensive rats (PVL) and sham-operated rats (CTR) were prepared and then the concentration of plasma ET-1 was measured and the vasopressor response to ET-1 was compared between the two groups. The plasma ET-1 levels in PVL increased significantly compared with CTR; however, the vasopressor response to ET-1 in PVL decreased more than in CTR. Next, the portal venous pressure was measured in both CTR and PVL pretreated with or without a nitric oxide (NO) synthase inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME), before the injection of ET-1. The portal venous pressure of PVL after receiving ET-1 and being pretreated with L-NAME significantly increased in comparison to the pressure of PVL treated with ET-1 alone (without L-NAME). Moreover, Evans-Blue was injected into each rat and the absorbancy of the gastric contents was measured. The absorbancy of Evans-Blue in PVL increased significantly compared with CTR; however, the absorbancy in PVL+ ET(A/B) receptor inhibitor (Ro47-0203) decreased significantly more than in PVL. Conclusions: This study showed that ET-1 is a potent vasoconstrictive substance that also has a transitory vasodilative response through NO induced by ET-1 in portal hypertension. In addition, it was found that the vascular permeability of the gastric mucosa increased in portal hypertension and that Ro47-0203 inhibited the hyper-permeability. Accordingly, ET-1 may, thus, play an important role in the development of PHG through NO induced by ET-1. Ro47- 0203 may, therefore, be a useful substance for improving PHG in portal hypertension. (C) 2000 Blackwell Science Asia Pty Ltd.

Original languageEnglish
Pages (from-to)142-147
Number of pages6
JournalJournal of Gastroenterology and Hepatology (Australia)
Issue number2
Publication statusPublished - 2000

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Role of endothelin-1 in congestive gastropathy in portal hypertensive rats'. Together they form a unique fingerprint.

Cite this